Elmind Capital, LP
Top Portfolio Positions
34 positions ·
$352,219,180 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
1,170,740 | $45,061,782 | 12.79% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
1,855,000 | $43,332,800 | 12.30% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
865,000 | $27,437,800 | 7.79% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
4,550,000 | $21,385,000 | 6.07% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
1,021,300 | $20,558,769 | 5.84% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
291,800 | $19,749,024 | 5.61% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
482,500 | $19,410,975 | 5.51% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
316,500 | $18,391,815 | 5.22% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
475,750 | $13,439,937 | 3.82% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
350,000 | $13,405,000 | 3.81% |
Portfolio Trend
2 quarters · across all stocks
Holdings in URGN
Shares Held
Position Value (USD)
2 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,955,600 | 220,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,342,000 | 100,000 | Shares | Sole | 2026-02-17 | |
| No 13F history on record for this holder in this stock. | ||||||